{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:02:54Z","timestamp":1792854174085,"version":"4.5.0"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-04084-3","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T08:13:35Z","timestamp":1765440815000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Theranostic potential of MXene-based platforms for dual MiRNA targeting in metastatic bladder cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Negar Nayerain","family":"Jazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Alavimanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Vafadar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maedeh","family":"Choubani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayan Khalili","family":"Alashti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Savardashtaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"issue":"5","key":"4084_CR1","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","volume":"20","author":"LM van Hoogstraten","year":"2023","unstructured":"van Hoogstraten LM, Vrieling A, van der Heijden AG, Kogevinas M, Richters A, Kiemeney LA. Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat Rev Clin Oncol. 2023;20(5):287\u2013304.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"4084_CR2","volume":"8","author":"K Saginala","year":"2020","unstructured":"Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A. Epidemiology of bladder cancer. Med Sci (Basel). 2020;8(1):15.","journal-title":"Med Sci (Basel)"},{"issue":"sup218","key":"4084_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/03008880802285032","volume":"42","author":"DM Parkin","year":"2008","unstructured":"Parkin DM. The global burden of urinary bladder cancer. Scand J Urol Nephrol. 2008;42(sup218):12\u201320.","journal-title":"Scand J Urol Nephrol"},{"key":"4084_CR4","first-page":"1","volume-title":"Metastasis\/Dissemination","author":"H Kaiser","year":"1989","unstructured":"Kaiser H. Overview of metastatic spreading. In: Metastasis\/Dissemination. Springer; 1989. p. 1\u201320."},{"issue":"1","key":"4084_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41568-020-00308-y","volume":"21","author":"S Rottenberg","year":"2021","unstructured":"Rottenberg S, Disler C, Perego P. The rediscovery of platinum-based cancer therapy. Nat Rev Cancer. 2021;21(1):37\u201350.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"4084_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01856-7","volume":"9","author":"B Liu","year":"2024","unstructured":"Liu B, Zhou H, Tan L, Siu KTH, Guan X-Y. Exploring treatment options in cancer: tumor treatment strategies. Signal Transduct Target Ther. 2024;9(1):175.","journal-title":"Signal Transduct Target Ther"},{"key":"4084_CR7","doi-asserted-by":"crossref","unstructured":"da Silvia Lima RQ, Vasconcelos CFM, Gomes JPA, de Menezes ESB, de Oliveira Silva B, Junior CCM, et al. miRNA-21, an oncomiR that regulates cell proliferation, migration, invasion and therapy response in lung cancer. Pathology-Research Pract. 2024;252:155601","DOI":"10.1016\/j.prp.2024.155601"},{"issue":"Suppl 1","key":"4084_CR8","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.4111\/icu.2016.57.S1.S60","volume":"57","author":"H Enokida","year":"2016","unstructured":"Enokida H, Yoshino H, Matsushita R, Nakagawa M. The role of MicroRNAs in bladder cancer. Invest Clin Urol. 2016;57(Suppl 1):S60\u201376.","journal-title":"Invest Clin Urol"},{"key":"4084_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00109-016-1420-5","volume":"94","author":"M Mutlu","year":"2016","unstructured":"Mutlu M, Raza U, Saatci \u00d6, Ey\u00fcpo\u011flu E, Yurdusev E, \u015eahin \u00d6. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance. J Mol Med. 2016;94:629\u201344.","journal-title":"J Mol Med"},{"key":"4084_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1378386","volume":"11","author":"J Chen","year":"2024","unstructured":"Chen J, He F, Peng H, Guo J. The underlying mechanism and targeted therapy strategy of miRNAs cross-regulating EMT process through multiple signaling pathways in hepatocellular carcinoma. Front Mol Biosci. 2024;11:1378386.","journal-title":"Front Mol Biosci"},{"issue":"8","key":"4084_CR11","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.3390\/pharmaceutics14081586","volume":"14","author":"J Huang","year":"2022","unstructured":"Huang J, Xiao K. Nanoparticles-based strategies to improve the delivery of therapeutic small interfering RNA in precision oncology. Pharmaceutics. 2022;14(8):1586.","journal-title":"Pharmaceutics"},{"issue":"6547","key":"4084_CR12","doi-asserted-by":"publisher","first-page":"eabf1581","DOI":"10.1126\/science.abf1581","volume":"372","author":"A VahidMohammadi","year":"2021","unstructured":"VahidMohammadi A, Rosen J, Gogotsi Y. The world of two-dimensional carbides and nitrides (MXenes). Science. 2021;372(6547):eabf1581.","journal-title":"Science"},{"key":"4084_CR13","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c11858","author":"X Bian","year":"2025","unstructured":"Bian X, Zhou L, Luo Z, Liu G, Hang Z, Li H, et al. Emerging delivery systems for enabling precision nucleic acid therapeutics. ACS Nano. 2025. https:\/\/doi.org\/10.1021\/acsnano.4c11858.","journal-title":"ACS Nano"},{"issue":"5","key":"4084_CR14","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1021\/acsagscitech.1c00146","volume":"1","author":"M Mujtaba","year":"2021","unstructured":"Mujtaba M, Wang D, Carvalho LB, Oliveira JL, Espirito Santo Pereira Ad, Sharif R, et al. Nanocarrier-mediated delivery of miRNA, RNAi, and CRISPR-Cas for plant protection: current trends and future directions. ACS Agricultural Science & Technology. 2021;1(5):417\u201335.","journal-title":"ACS Agricultural Science & Technology"},{"key":"4084_CR15","first-page":"409","volume":"20","author":"D Bautista-S\u00e1nchez","year":"2020","unstructured":"Bautista-S\u00e1nchez D, Arriaga-Canon C, Pedroza-Torres A, De La Rosa-Vel\u00e1zquez IA, Gonz\u00e1lez-Barrios R, Contreras-Espinosa L, et al. The promising role of miR-21 as a cancer biomarker and its importance in RNA-based therapeutics. Mol Ther. 2020;20:409\u201320.","journal-title":"Mol Ther"},{"issue":"1","key":"4084_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-022-00413-7","volume":"11","author":"LH Chi","year":"2022","unstructured":"Chi LH, Cross RSN, Redvers RP, Davis M, Hediyeh-Zadeh S, Mathivanan S, et al. MicroRNA-21 is immunosuppressive and pro-metastatic via separate mechanisms. Oncogenesis. 2022;11(1):38.","journal-title":"Oncogenesis"},{"issue":"1","key":"4084_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","volume":"302","author":"B Zhang","year":"2007","unstructured":"Zhang B, Pan X, Cobb GP, Anderson TA. MicroRNAs as oncogenes and tumor suppressors. Dev Biol. 2007;302(1):1\u201312.","journal-title":"Dev Biol"},{"issue":"3","key":"4084_CR18","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/cr.2008.24","volume":"18","author":"S Zhu","year":"2008","unstructured":"Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 2008;18(3):350\u20139.","journal-title":"Cell Res"},{"issue":"3","key":"4084_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.5114\/fn.2021.108695","volume":"59","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Yang SZ, Qi YF, Yin Y. Identification of miR-21-5p\/TET1-negative regulation pair in the aggressiveness of glioma cells. Folia Neuropathol. 2021;59(3):239\u201348.","journal-title":"Folia Neuropathol"},{"issue":"9","key":"4084_CR20","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41419-018-0928-8","volume":"9","author":"Q Li","year":"2018","unstructured":"Li Q, Li B, Li Q, Wei S, He Z, Huang X, et al. Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition. Cell Death Dis. 2018;9(9):854.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4084_CR21","first-page":"228","volume":"19","author":"L Li","year":"2014","unstructured":"Li L, Zhou L, Li Y, Lin S, Tomuleasa C. MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog. J Buon. 2014;19(1):228\u201336.","journal-title":"J Buon"},{"issue":"1","key":"4084_CR22","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s13046-018-0965-2","volume":"37","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Ren H, Dai B, Li J, Shang L, Huang J, et al. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts. J Exp Clin Cancer Res. 2018;37(1):324.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"4084_CR23","first-page":"1036","volume":"15","author":"C Li","year":"2018","unstructured":"Li C, Xu B, Miu X, Deng Z, Liao H, Hao L. Inhibition of miRNA-21 attenuates the proliferation and metastasis of human osteosarcoma by upregulating PTEN. Exp Ther Med. 2018;15(1):1036\u201340.","journal-title":"Exp Ther Med"},{"issue":"4","key":"4084_CR24","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.sjbs.2018.12.009","volume":"26","author":"S Wang","year":"2019","unstructured":"Wang S, Wang Z, Wang Q, Cui Y, Luo S. Clinical significance of the expression of miRNA-21, miRNA-31 and miRNA-let7 in patients with lung cancer. Saudi J Biol Sci. 2019;26(4):777\u201381.","journal-title":"Saudi J Biol Sci"},{"issue":"7","key":"4084_CR25","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nrurol.2013.113","volume":"10","author":"H Yoshino","year":"2013","unstructured":"Yoshino H, Seki N, Itesako T, Chiyomaru T, Nakagawa M, Enokida H. Aberrant expression of microRNAs in bladder cancer. Nat Rev Urol. 2013;10(7):396\u2013404.","journal-title":"Nat Rev Urol"},{"issue":"9","key":"4084_CR26","doi-asserted-by":"publisher","first-page":"12061","DOI":"10.1007\/s13277-016-5074-2","volume":"37","author":"YR Wu","year":"2016","unstructured":"Wu YR, Qi HJ, Deng DF, Luo YY, Yang SL. MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN\/PI3K\/AKT signaling pathway in esophageal cancer. Tumour Biol. 2016;37(9):12061\u201370.","journal-title":"Tumour Biol"},{"issue":"9","key":"4084_CR27","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41580-018-0015-0","volume":"19","author":"YR Lee","year":"2018","unstructured":"Lee YR, Chen M, Pandolfi PP. The functions and regulation of the PTEN tumour suppressor: new modes and prospects. Nat Rev Mol Cell Biol. 2018;19(9):547\u201362.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"4084_CR28","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22(1):138.","journal-title":"Mol Cancer"},{"key":"4084_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.819128","volume":"12","author":"Y Peng","year":"2022","unstructured":"Peng Y, Wang Y, Zhou C, Mei W, Zeng C. PI3K\/Akt\/mTOR pathway and its role in cancer therapeutics: are we making headway? Front Oncol. 2022;12:819128.","journal-title":"Front Oncol"},{"issue":"36","key":"4084_CR30","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1038\/onc.2015.515","volume":"35","author":"J Musa","year":"2016","unstructured":"Musa J, Orth MF, Dallmayer M, Baldauf M, Pardo C, Rotblat B, et al. Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis. Oncogene. 2016;35(36):4675\u201388.","journal-title":"Oncogene"},{"issue":"5","key":"4084_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2020.118659","volume":"1867","author":"J Lin","year":"2020","unstructured":"Lin J, Song T, Li C, Mao W. GSK-3\u03b2 in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer. Biochimica et Biophysica Acta (BBA). 2020;1867(5):118659.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"6","key":"4084_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100773","volume":"13","author":"D Ribatti","year":"2020","unstructured":"Ribatti D, Tamma R, Annese T. Epithelial-mesenchymal transition in cancer: a historical overview. Transl Oncol. 2020;13(6):100773.","journal-title":"Transl Oncol"},{"issue":"2","key":"4084_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-021-04104-1","volume":"79","author":"A G\u00f3rska","year":"2022","unstructured":"G\u00f3rska A, Mazur AJ. Integrin-linked kinase (ILK): the known vs. the unknown and perspectives. Cell Mol Life Sci. 2022;79(2):100.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"4084_CR34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/onc.2012.30","volume":"32","author":"I Serrano","year":"2013","unstructured":"Serrano I, McDonald PC, Lock FE, Dedhar S. Role of the integrin-linked kinase (ILK)\/Rictor complex in TGF\u03b2-1-induced epithelial-mesenchymal transition (EMT). Oncogene. 2013;32(1):50\u201360.","journal-title":"Oncogene"},{"issue":"4","key":"4084_CR35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/19336918.2015.1016686","volume":"9","author":"W Xu","year":"2015","unstructured":"Xu W, Yang Z, Lu N. A new role for the PI3K\/Akt signaling pathway in the epithelial-mesenchymal transition. Cell Adh Migr. 2015;9(4):317\u201324.","journal-title":"Cell Adh Migr"},{"key":"4084_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116685","volume":"175","author":"L Sun","year":"2024","unstructured":"Sun L, Xing J, Zhou X, Song X, Gao S. Wnt\/\u03b2-catenin signalling, epithelial-mesenchymal transition and crosslink signalling in colorectal cancer cells. Biomed Pharmacother. 2024;175:116685.","journal-title":"Biomed Pharmacother"},{"key":"4084_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106568","volume":"187","author":"M Hashemi","year":"2023","unstructured":"Hashemi M, Mirdamadi MSA, Talebi Y, Khaniabad N, Banaei G, Daneii P, et al. Pre-clinical and clinical importance of miR-21 in human cancers: tumorigenesis, therapy response, delivery approaches and targeting agents. Pharmacol Res. 2023;187:106568.","journal-title":"Pharmacol Res"},{"key":"4084_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.808475","volume":"12","author":"S Ghafouri-Fard","year":"2022","unstructured":"Ghafouri-Fard S, Hussen BM, Mohaqiq M, Shoorei H, Baniahmad A, Taheri M, et al. Interplay between non-coding RNAs and programmed cell death proteins. Front Oncol. 2022;12:808475.","journal-title":"Front Oncol"},{"issue":"12","key":"4084_CR39","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1002\/ijc.24748","volume":"125","author":"D Bai","year":"2009","unstructured":"Bai D, Ueno L, Vogt PK. Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt. Int J Cancer. 2009;125(12):2863\u201370.","journal-title":"Int J Cancer"},{"issue":"10","key":"4084_CR40","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1172\/JCI26322","volume":"115","author":"JL Luo","year":"2005","unstructured":"Luo JL, Kamata H, Karin M. IKK\/NF-kappaB signaling: balancing life and death\u2013a new approach to cancer therapy. J Clin Invest. 2005;115(10):2625\u201332.","journal-title":"J Clin Invest"},{"key":"4084_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6071826","volume":"2018","author":"W Liu","year":"2018","unstructured":"Liu W, Zhang K, Wei P, Hu Y, Peng Y, Fang X, et al. Correlation between miR-200 family overexpression and cancer prognosis. Dis Markers. 2018;2018:6071826.","journal-title":"Dis Markers"},{"key":"4084_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.965231","volume":"12","author":"K Klicka","year":"2022","unstructured":"Klicka K, Grzywa TM, Mielniczuk A, Klinke A, W\u0142odarski PK. The role of mir-200 family in the regulation of hallmarks of cancer. Front Oncol. 2022;12:965231.","journal-title":"Front Oncol"},{"key":"4084_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102216","volume":"51","author":"MS Kishta","year":"2025","unstructured":"Kishta MS, Khamis A, Am H, Elshaar AH, G\u00fcl D. Exploring the tumor-suppressive role of miRNA-200c in head and neck squamous cell carcinoma: potential and mechanisms of exosome-mediated delivery for therapeutic applications. Transl Oncol. 2025;51:102216.","journal-title":"Transl Oncol"},{"issue":"1","key":"4084_CR44","first-page":"91","volume":"39","author":"A Kurata","year":"2018","unstructured":"Kurata A, Yamada M, Ohno SI, Inoue S, Hashimoto H, Fujita K, et al. Expression level of microRNA-200c is associated with cell morphology in vitro and histological differentiation through regulation of ZEB1\/2 and E-cadherin in gastric carcinoma. Oncol Rep. 2018;39(1):91\u2013100.","journal-title":"Oncol Rep"},{"key":"4084_CR45","doi-asserted-by":"publisher","first-page":"5139","DOI":"10.12659\/MSM.907207","volume":"23","author":"F Li","year":"2017","unstructured":"Li F, Liang A, Lv Y, Liu G, Jiang A, Liu P. Microrna-200c inhibits epithelial-mesenchymal transition by targeting the BMI-1 gene through the phospho-AKT pathway in endometrial carcinoma cells in vitro. Med Sci Monit. 2017;23:5139\u201349.","journal-title":"Med Sci Monit"},{"key":"4084_CR46","doi-asserted-by":"crossref","unstructured":"Wang MC, Li CL, Cui J, Jiao M, Wu T,\u00a0Jing\u00a0LI, et al. BMI-1, a promising therapeutic target for human cancer. Oncol Lett. 2015;10(2):583\u20138.","DOI":"10.3892\/ol.2015.3361"},{"issue":"19","key":"4084_CR47","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1177\/15353702211035693","volume":"246","author":"S Jusino","year":"2021","unstructured":"Jusino S, Rivera-Rivera Y, Chard\u00f3n-Col\u00f3n C, Ruiz-Justiz AJ, V\u00e9lez-Vel\u00e1zquez J, Isidro A, et al. E2F3 drives the epithelial-to-mesenchymal transition, cell invasion, and metastasis in breast cancer. Exp Biol Med (Maywood). 2021;246(19):2057\u201371.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"33","key":"4084_CR48","doi-asserted-by":"publisher","first-page":"54021","DOI":"10.18632\/oncotarget.10568","volume":"8","author":"Y Gao","year":"2017","unstructured":"Gao Y, Li H, Ma X, Fan Y, Ni D, Zhang Y, et al. E2F3 upregulation promotes tumor malignancy through the transcriptional activation of HIF-2\u03b1 in clear cell renal cell carcinoma. Oncotarget. 2017;8(33):54021\u201336.","journal-title":"Oncotarget"},{"key":"4084_CR49","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12967-014-0305-z","volume":"12","author":"L Liu","year":"2014","unstructured":"Liu L, Qiu M, Tan G, Liang Z, Qin Y, Chen L, et al. Mir-200c inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3. J Transl Med. 2014;12:305.","journal-title":"J Transl Med"},{"issue":"7","key":"4084_CR50","doi-asserted-by":"publisher","first-page":"e0180844","DOI":"10.1371\/journal.pone.0180844","volume":"12","author":"PL Liu","year":"2017","unstructured":"Liu PL, Liu WL, Chang JM, Chen YH, Liu YP, Kuo HF, et al. Microrna-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1. PLoS One. 2017;12(7):e0180844.","journal-title":"PLoS One"},{"issue":"3","key":"4084_CR51","doi-asserted-by":"publisher","first-page":"110634","DOI":"10.1016\/j.ygeno.2023.110634","volume":"115","author":"Z Li","year":"2023","unstructured":"Li Z, Wu X, Chen S, Zhong J, Qiu X, Kpegah J, et al. Identification of CRKL as an oncogenic biomarker for prognosis and immunotherapy in melanoma, and its potential molecular mechanism. Genomics. 2023;115(3):110634.","journal-title":"Genomics"},{"issue":"1","key":"4084_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-024-01004-1","volume":"15","author":"F Nie","year":"2024","unstructured":"Nie F, Zhang Q, Ma W, Yan J. miRNA-200c-3p deficiency promotes epithelial-mesenchymal transition in triple-negative breast cancer by activating CRKL expression. Discov Oncol. 2024;15(1):146.","journal-title":"Discov Oncol"},{"key":"4084_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040739","author":"T Park","year":"2021","unstructured":"Park T. Crk and CrkL as therapeutic targets for cancer treatment. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10040739.","journal-title":"Cells"},{"issue":"6","key":"4084_CR54","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00109-016-1420-5","volume":"94","author":"M Mutlu","year":"2016","unstructured":"Mutlu M, Raza U, Saatci \u00d6, Ey\u00fcpo\u011flu E, Yurdusev E, \u015eahin \u00d6. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance. J Mol Med (Berl). 2016;94(6):629\u201344.","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"4084_CR55","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3892\/or.2017.5659","volume":"38","author":"T Jiang","year":"2017","unstructured":"Jiang T, Dong P, Li L, Ma X, Xu P, Zhu H, et al. MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells. Oncol Rep. 2017;38(1):151\u20138.","journal-title":"Oncol Rep"},{"issue":"4","key":"4084_CR56","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/ijc.27708","volume":"132","author":"L Hill","year":"2013","unstructured":"Hill L, Browne G, Tulchinsky E. ZEB\/miR-200 feedback loop: at the crossroads of signal transduction in cancer. Int J Cancer. 2013;132(4):745\u201354.","journal-title":"Int J Cancer"},{"key":"4084_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/biom10071040","author":"M Ashrafizadeh","year":"2020","unstructured":"Ashrafizadeh M, Ang HL, Moghadam ER, Mohammadi S, Zarrin V, Hushmandi K, et al. MicroRNAs and their influence on the ZEB family: mechanistic aspects and therapeutic applications in cancer therapy. Biomolecules. 2020. https:\/\/doi.org\/10.3390\/biom10071040.","journal-title":"Biomolecules"},{"issue":"1","key":"4084_CR58","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1423-0127-19-90","volume":"19","author":"PS Chen","year":"2012","unstructured":"Chen PS, Su JL, Hung MC. Dysregulation of microRNAs in cancer. J Biomed Sci. 2012;19(1):90.","journal-title":"J Biomed Sci"},{"issue":"4","key":"4084_CR59","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.3390\/cimb44040121","volume":"44","author":"O Aghiorghiesei","year":"2022","unstructured":"Aghiorghiesei O, Zanoaga O, Raduly L, Aghiorghiesei AI, Chiroi P, Trif A, et al. Dysregulation of miR-21-5p, miR-93-5p, miR-200c-3p and miR-205-5p in oral squamous cell carcinoma: a potential biomarkers panel? Curr Issues Mol Biol. 2022;44(4):1754\u201367.","journal-title":"Curr Issues Mol Biol"},{"key":"4084_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/cells11182791","author":"J Rhim","year":"2022","unstructured":"Rhim J, Baek W, Seo Y, Kim JH. From molecular mechanisms to therapeutics: understanding MicroRNA-21 in cancer. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11182791.","journal-title":"Cells"},{"issue":"4","key":"4084_CR61","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3892\/etm.2017.4147","volume":"13","author":"M Qiu","year":"2017","unstructured":"Qiu M, Liang Z, Chen L, Tan G, Liu L, Wang K, et al. MicroRNA-200c suppresses cell growth and metastasis by targeting Bmi-1 and E2F3 in renal cancer cells. Exp Ther Med. 2017;13(4):1329\u201336.","journal-title":"Exp Ther Med"},{"issue":"9","key":"4084_CR62","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2174\/1568009621666210601114631","volume":"21","author":"L Soleymani","year":"2021","unstructured":"Soleymani L, Zarrabi A, Hashemi F, Hashemi F, Zabolian A, Banihashemi SM, et al. Role of ZEB family members in proliferation, metastasis, and chemoresistance of prostate cancer cells: revealing signaling networks. Curr Cancer Drug Targets. 2021;21(9):749\u201367.","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"4084_CR63","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00428-020-02817-5","volume":"477","author":"K Quiohilag","year":"2020","unstructured":"Quiohilag K, Caie P, Oniscu A, Brenn T, Harrison D. The differential expression of micro-RNAs 21, 200c, 204, 205, and 211 in benign, dysplastic and malignant melanocytic lesions and critical evaluation of their role as diagnostic biomarkers. Virchows Arch. 2020;477(1):121\u201330.","journal-title":"Virchows Arch"},{"issue":"4","key":"4084_CR64","first-page":"986","volume":"56","author":"HH Zhang","year":"2020","unstructured":"Zhang HH, Huang ZX, Zhong SQ, Fei KL, Cao YH. miR\u201321 inhibits autophagy and promotes malignant development in the bladder cancer T24 cell line. Int J Oncol. 2020;56(4):986\u201398.","journal-title":"Int J Oncol"},{"key":"4084_CR65","doi-asserted-by":"publisher","first-page":"1437951","DOI":"10.3389\/fcell.2024.1437951","volume":"12","author":"L Gan","year":"2024","unstructured":"Gan L, Zheng L, Zou J, Luo P, Chen T, Zou J, et al. MicroRNA-21 in urologic cancers: from molecular mechanisms to clinical implications. Front Cell Dev Biol. 2024;12:1437951.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"4084_CR66","doi-asserted-by":"publisher","first-page":"283","DOI":"10.4103\/iju.IJU_4_17","volume":"33","author":"N Mitash","year":"2017","unstructured":"Mitash N, Agnihotri S, Tiwari S, Agrawal V, Mandhani A. MicroRNA-21 could be a molecular marker to predict the recurrence of nonmuscle invasive bladder cancer. Indian J Urol. 2017;33(4):283\u201390.","journal-title":"Indian J Urol"},{"key":"4084_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-018-0540-0","volume":"18","author":"R Xu","year":"2018","unstructured":"Xu R, Zhu X, Chen F, Huang C, Ai K, Wu H, et al. LncRNA XIST\/miR-200c regulates the stemness properties and tumourigenicity of human bladder cancer stem cell-like cells. Cancer Cell Int. 2018;18:41.","journal-title":"Cancer Cell Int"},{"issue":"8","key":"4084_CR68","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.21037\/tcr.2019.10.23","volume":"8","author":"SQ Wu","year":"2019","unstructured":"Wu SQ, He HQ, Kang Y, Xu R, Zhang L, Zhao XK, et al. MicroRNA-200c affects bladder cancer angiogenesis by regulating the Akt2\/mTOR\/HIF-1 axis. Transl Cancer Res. 2019;8(8):2713\u201324.","journal-title":"Transl Cancer Res"},{"issue":"40","key":"4084_CR69","doi-asserted-by":"publisher","first-page":"67663","DOI":"10.18632\/oncotarget.18801","volume":"8","author":"D Yuan","year":"2017","unstructured":"Yuan D, Zheng S, Wang L, Li J, Yang J, Wang B, et al. Mir-200c inhibits bladder cancer progression by targeting lactate dehydrogenase A. Oncotarget. 2017;8(40):67663\u20139.","journal-title":"Oncotarget"},{"issue":"9","key":"4084_CR70","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3390\/bios12090743","volume":"12","author":"SM Mousavi","year":"2022","unstructured":"Mousavi SM, Hashemi SA, Kalashgrani MY, Rahmanian V, Gholami A, Chiang W-H, et al. Biomedical applications of an ultra-sensitive surface plasmon resonance biosensor based on smart MXene quantum Dots (SMQDs). Biosensors. 2022;12(9):743.","journal-title":"Biosensors"},{"key":"4084_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2022.215002","volume":"479","author":"G Yang","year":"2023","unstructured":"Yang G, Liu F, Zhao J, Fu L, Gu Y, Qu L, et al. MXenes-based nanomaterials for biosensing and biomedicine. Coord Chem Rev. 2023;479:215002.","journal-title":"Coord Chem Rev"},{"issue":"12","key":"4084_CR72","doi-asserted-by":"publisher","DOI":"10.1002\/anbr.202400136","volume":"4","author":"K Ariga","year":"2024","unstructured":"Ariga K. Nanoarchitectonics for biomedical research: post-nanotechnology materials approach for bio\u2010active application. Adv NanoBiomed Res. 2024;4(12):2400136.","journal-title":"Adv NanoBiomed Res"},{"key":"4084_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/agt2.700","author":"J Wang","year":"2024","unstructured":"Wang J, Wang Y, Lu M, Cao X, Xia M, Zhao M, et al. Biomimetic triplet messenger RNA formulation in MXene hydrogel microneedles for wound healing. Aggregate. 2024. https:\/\/doi.org\/10.1002\/agt2.700.","journal-title":"Aggregate"},{"key":"4084_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12938-021-00873-9","volume":"20","author":"A Zamhuri","year":"2021","unstructured":"Zamhuri A, Lim GP, Ma NL, Tee KS, Soon CF. MXene in the lens of biomedical engineering: synthesis, applications and future outlook. Biomed Eng Online. 2021;20:1\u201324.","journal-title":"Biomed Eng Online"},{"issue":"4","key":"4084_CR75","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1039\/D3MH01588B","volume":"11","author":"I-C Lee","year":"2024","unstructured":"Lee I-C, Li Y-CE, Thomas JL, Lee M-H, Lin H-Y. Recent advances using MXenes in biomedical applications. Mater Horiz. 2024;11(4):876\u2013902.","journal-title":"Mater Horiz"},{"issue":"20","key":"4084_CR76","doi-asserted-by":"publisher","first-page":"6687","DOI":"10.1039\/D3BM01114C","volume":"11","author":"A Zarepour","year":"2023","unstructured":"Zarepour A, Karasu \u00c7, Mir Y, Nematollahi MH, Iravani S, Zarrabi A. Graphene-and MXene-based materials for neuroscience: diagnostic and therapeutic applications. Biomater Sci. 2023;11(20):6687\u2013710.","journal-title":"Biomater Sci"},{"issue":"7","key":"4084_CR77","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3390\/bios12070454","volume":"12","author":"A Koyappayil","year":"2022","unstructured":"Koyappayil A, Chavan SG, Roh Y-G, Lee M-H. Advances of MXenes; perspectives on biomedical research. Biosensors. 2022;12(7):454.","journal-title":"Biosensors"},{"issue":"6","key":"4084_CR78","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1021\/acsmaterialsau.2c00042","volume":"2","author":"DP Sousa","year":"2022","unstructured":"Sousa DP, Conde J. Gold nanoconjugates for miRNA modulation in cancer therapy: from miRNA silencing to miRNA mimics. ACS Mater Au. 2022;2(6):626\u201340.","journal-title":"ACS Mater Au"},{"issue":"22","key":"4084_CR79","doi-asserted-by":"publisher","first-page":"7277","DOI":"10.1039\/D1MA00625H","volume":"2","author":"M Mozafari","year":"2021","unstructured":"Mozafari M, Soroush M. Surface functionalization of MXenes. Mater Adv. 2021;2(22):7277\u2013307.","journal-title":"Mater Adv"},{"issue":"12","key":"4084_CR80","doi-asserted-by":"publisher","first-page":"19600","DOI":"10.1021\/acsnano.1c06670","volume":"15","author":"JT Lee","year":"2021","unstructured":"Lee JT, Wyatt BC, Davis Jr GA, Masterson AN, Pagan AL, Shah A, et al. Covalent surface modification of Ti3C2T x MXene with chemically active polymeric ligands producing highly conductive and ordered microstructure films. ACS Nano. 2021;15(12):19600\u201312.","journal-title":"ACS Nano"},{"issue":"8","key":"4084_CR81","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1039\/D0CS01487G","volume":"51","author":"J Zou","year":"2022","unstructured":"Zou J, Wu J, Wang Y, Deng F, Jiang J, Zhang Y, et al. Additive-mediated intercalation and surface modification of MXenes. Chem Soc Rev. 2022;51(8):2972\u201390.","journal-title":"Chem Soc Rev"},{"issue":"19","key":"4084_CR82","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.1039\/D3QM00220A","volume":"7","author":"H Lu","year":"2023","unstructured":"Lu H, Wang J, Li H, Zhou W, Yuan Q, Liu S. Efficient photothermal conversion of MXenes and their application in biomedicine. Mater Chem Front. 2023;7(19):4372\u201399.","journal-title":"Mater Chem Front"},{"key":"4084_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fnano.2021.689718","volume":"3","author":"S Shurbaji","year":"2021","unstructured":"Shurbaji S, Manaph NPA, Ltaief SM, Al-Shammari AR, Elzatahry A, Yalcin HC. Characterization of MXene as a cancer photothermal agent under physiological conditions. Front Nanotechnol. 2021;3:689718.","journal-title":"Front Nanotechnol"},{"issue":"11","key":"4084_CR84","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1007\/s11426-022-1376-1","volume":"65","author":"S Wang","year":"2022","unstructured":"Wang S, Zhang Z, Tang R, He F, Huang Y, Nie Z, et al. Responsive MXene nanovehicles deliver CRISPR\/Cas12a for boolean logic-controlled gene editing. Sci China Chem. 2022;65(11):2318\u201326.","journal-title":"Sci China Chem"},{"issue":"43","key":"4084_CR85","doi-asserted-by":"publisher","first-page":"10010","DOI":"10.1039\/C9SC03049B","volume":"10","author":"CL Manzanares-Palenzuela","year":"2019","unstructured":"Manzanares-Palenzuela CL, Pourrahimi AM, Gonzalez-Julian J, Sofer Z, Pykal M, Otyepka M, et al. Interaction of single-and double-stranded DNA with multilayer MXene by fluorescence spectroscopy and molecular dynamics simulations. Chem Sci. 2019;10(43):10010\u20137.","journal-title":"Chem Sci"},{"key":"4084_CR86","doi-asserted-by":"crossref","unstructured":"0. Gayathri VG, Bartholomew R, Chacko JT, Bayry J, Rasheed PA. Non-Ti MXenes: new biocompatible and biodegradable candidates for biomedical applications. J Mater Chem. 2025; 13(4): 1212-1228.","DOI":"10.1039\/D4TB01904K"},{"key":"4084_CR87","doi-asserted-by":"publisher","first-page":"1485437","DOI":"10.3389\/fbioe.2024.1485437","volume":"12","author":"J Li","year":"2024","unstructured":"Li J, Fan Z, Guan Z, Ruan J. Injectable MXene\/Ag-HA composite hydrogel for enhanced alveolar bone healing and mechanistic study. Front Bioeng Biotechnol. 2024;12:1485437.","journal-title":"Front Bioeng Biotechnol"},{"issue":"19","key":"4084_CR88","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.3390\/nano12193360","volume":"12","author":"S Iravani","year":"2022","unstructured":"Iravani S, Varma RS. MXenes in cancer nanotheranostics. Nanomaterials. 2022;12(19):3360.","journal-title":"Nanomaterials"},{"issue":"40","key":"4084_CR89","doi-asserted-by":"publisher","first-page":"16036","DOI":"10.1021\/acs.analchem.4c03628","volume":"96","author":"L Zhang","year":"2024","unstructured":"Zhang L, Zhang Q, Chen D, Deng Y, Wang R, Wang S. Titanium carbide-based spatiotemporally selectable-activated entropy-driven DNA nanoplatform for amplified MicroRNA imaging and photothermal therapy in vivo. Anal Chem. 2024;96(40):16036\u201344.","journal-title":"Anal Chem"},{"issue":"8","key":"4084_CR90","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1515\/nanoph-2019-0571","volume":"9","author":"Z Huang","year":"2020","unstructured":"Huang Z, Cui X, Li S, Wei J, Li P, Wang Y, et al. Two-dimensional MXene-based materials for photothermal therapy. Nanophotonics. 2020;9(8):2233\u201349.","journal-title":"Nanophotonics"},{"key":"4084_CR91","doi-asserted-by":"publisher","first-page":"984336","DOI":"10.3389\/fbioe.2022.984336","volume":"10","author":"S Ranjbari","year":"2022","unstructured":"Ranjbari S, Darroudi M, Hatamluyi B, Arefinia R, Aghaee-Bakhtiari SH, Rezayi M, et al. Application of MXene in the diagnosis and treatment of breast cancer: a critical overview. Front Bioeng Biotechnol. 2022;10:984336.","journal-title":"Front Bioeng Biotechnol"},{"key":"4084_CR92","doi-asserted-by":"crossref","unstructured":"Rahim FA, Niyas K, Pathan SY, Vivek R, Rasheed PA. An overview on the use of non-Titanium MXenes for photothermal therapy and its combinational approach for cancer treatment. Nanoscale Adv. 2025; 7(2): 620\u2013638.","DOI":"10.1039\/D4NA00931B"},{"key":"4084_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113496","volume":"153","author":"G Perini","year":"2022","unstructured":"Perini G, Rosenkranz A, Friggeri G, Zambrano D, Rosa E, Augello A, et al. Advanced usage of Ti3C2Tx MXenes for photothermal therapy on different 3D breast cancer models. Biomed Pharmacother. 2022;153:113496.","journal-title":"Biomed Pharmacother"},{"issue":"17","key":"4084_CR94","doi-asserted-by":"publisher","first-page":"8640","DOI":"10.1021\/acs.analchem.6b01804","volume":"88","author":"R-C Qian","year":"2016","unstructured":"Qian R-C, Cao Y, Long Y-T. Binary system for microRNA-targeted imaging in single cells and photothermal cancer therapy. Anal Chem. 2016;88(17):8640\u20137.","journal-title":"Anal Chem"},{"issue":"26","key":"4084_CR95","doi-asserted-by":"publisher","first-page":"5195","DOI":"10.1039\/D1TB00410G","volume":"9","author":"M Huang","year":"2021","unstructured":"Huang M, Gu Z, Zhang J, Zhang D, Zhang H, Yang Z, et al. MXene and black phosphorus based 2D nanomaterials in bioimaging and biosensing: progress and perspectives. J Mater Chem B. 2021;9(26):5195\u2013220.","journal-title":"J Mater Chem B"},{"issue":"2","key":"4084_CR96","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/php.13184","volume":"96","author":"BC Wilson","year":"2020","unstructured":"Wilson BC, Weersink RA. The yin and yang of PDT and PTT. Photochem Photobiol. 2020;96(2):219\u201331.","journal-title":"Photochem Photobiol"},{"issue":"44","key":"4084_CR97","doi-asserted-by":"publisher","first-page":"1702299","DOI":"10.1002\/smll.201702299","volume":"13","author":"K Deng","year":"2017","unstructured":"Deng K, Li C, Huang S, Xing B, Jin D, Zeng Q, et al. Recent progress in near infrared light triggered photodynamic therapy. Small. 2017;13(44):1702299.","journal-title":"Small"},{"key":"4084_CR98","first-page":"874","volume":"98","author":"A Szuplewska","year":"2019","unstructured":"Szuplewska A, Kulpi\u0144ska D, Dybko A, Jastrz\u0119bska AM, Wojciechowski T, Rozmys\u0142owska A, et al. 2D Ti2C (MXene) as a novel highly efficient and selective agent for photothermal therapy. Materials Science and Engineering: C. 2019;98:874\u201386.","journal-title":"Materials Science and Engineering: C"},{"issue":"9","key":"4084_CR99","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201701394","volume":"7","author":"X Han","year":"2018","unstructured":"Han X, Huang J, Lin H, Wang Z, Li P, Chen Y. 2D ultrathin MXene-based drug\u2010delivery nanoplatform for synergistic photothermal ablation and chemotherapy of cancer. Adv Healthc Mater. 2018;7(9):1701394.","journal-title":"Adv Healthc Mater"},{"key":"4084_CR100","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.actbio.2023.01.049","volume":"159","author":"T Liao","year":"2023","unstructured":"Liao T, Chen Z, Kuang Y, Ren Z, Yu W, Rao W, et al. Small-size Ti3C2Tx MXene nanosheets coated with metal-polyphenol nanodots for enhanced cancer photothermal therapy and anti-inflammation. Acta Biomater. 2023;159:312\u201323.","journal-title":"Acta Biomater"},{"issue":"6","key":"4084_CR101","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202305645","volume":"20","author":"N Li","year":"2024","unstructured":"Li N, Wang Y, Li Y, Zhang C, Fang G. Recent advances in photothermal therapy at near-infrared\u2010II based on 2D MXenes. Small. 2024;20(6):2305645.","journal-title":"Small"},{"key":"4084_CR102","doi-asserted-by":"publisher","DOI":"10.1039\/D4MH00819G","author":"Y Yang","year":"2024","unstructured":"Yang Y, Jiang S, Stanciu S, Peng H, Wu A, Yang F. Photodynamic therapy with NIR-II probes: review on state-of-the-art tools and strategies. Mater Horiz. 2024. https:\/\/doi.org\/10.1039\/D4MH00819G.","journal-title":"Mater Horiz"},{"issue":"5","key":"4084_CR103","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202300268","volume":"7","author":"B Singh","year":"2024","unstructured":"Singh B, Bahadur R, Rai D, Srivastava R. Preclinical toxicity assessment of Ti-based MXene nanomaterials for advanced theranostic applications. Adv Ther. 2024;7(5):2300268.","journal-title":"Adv Ther"},{"issue":"14","key":"4084_CR104","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1039\/D4TB02834A","volume":"13","author":"T Dutta","year":"2025","unstructured":"Dutta T, Alam P, Mishra SK. MXenes and MXene-based composites for biomedical applications. J Mater Chem B. 2025;13(14):4279\u2013312.","journal-title":"J Mater Chem B"},{"issue":"17","key":"4084_CR105","doi-asserted-by":"publisher","first-page":"6599","DOI":"10.1021\/acs.analchem.2c00712","volume":"94","author":"F Yang","year":"2022","unstructured":"Yang F, Yang Q, Yang L, Li J, Zhang Y, Lu H, et al. Endogenous microRNA accurate diagnostics to guide photothermal therapy. Anal Chem. 2022;94(17):6599\u2013606.","journal-title":"Anal Chem"},{"key":"4084_CR106","doi-asserted-by":"crossref","unstructured":"Sundramoorthy AK. Two-Dimensional MXene (Ti3C2Tx)-based Nano-Photosensitizers for enhanced photothermal ablation of tumor cells. Micro and Nanosystems. 2024.","DOI":"10.2174\/0118764029342774241024093132"},{"issue":"15","key":"4084_CR107","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1002\/adfm.201504912","volume":"26","author":"S Huang","year":"2016","unstructured":"Huang S, Duan S, Wang J, Bao S, Qiu X, Li C, et al. Folic-acid\u2010mediated functionalized gold nanocages for targeted delivery of anti\u2010miR\u2010181b in combination of gene therapy and photothermal therapy against hepatocellular carcinoma. Adv Funct Mater. 2016;26(15):2532\u201344.","journal-title":"Adv Funct Mater"},{"issue":"4","key":"4084_CR108","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2174\/1568009618666181016144855","volume":"19","author":"L-J Yan","year":"2019","unstructured":"Yan L-J, Guo X-H, Wang W-P, Hu Y-R, Duan S-F, Liu Y, et al. Gene therapy and photothermal therapy of layer-by-layer assembled AuNCs\/PEI\/miRNA\/HA nanocomplexes. Curr Cancer Drug Targets. 2019;19(4):330\u20137.","journal-title":"Curr Cancer Drug Targets"},{"key":"4084_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.matdes.2022.110887","volume":"220","author":"Y Lin","year":"2022","unstructured":"Lin Y, Xu S, Zhao X, Chang L, Hu Y, Chen Z, et al. Preparation of NIR-sensitive, photothermal and photodynamic multi-functional Mxene nanosheets for laryngeal cancer therapy by regulating mitochondrial apoptosis. Mater Des. 2022;220:110887.","journal-title":"Mater Des"},{"issue":"1","key":"4084_CR110","doi-asserted-by":"publisher","DOI":"10.1002\/anbr.202200123","volume":"3","author":"SS Siwal","year":"2023","unstructured":"Siwal SS, Kaur H, Chauhan G, Thakur VK. MXene-based nanomaterials for biomedical applications: healthier substitute materials for the future. Adv NanoBiomed Res. 2023;3(1):2200123.","journal-title":"Adv NanoBiomed Res"},{"issue":"5","key":"4084_CR111","doi-asserted-by":"publisher","first-page":"828","DOI":"10.3390\/nano12050828","volume":"12","author":"J Wu","year":"2022","unstructured":"Wu J, Yu Y, Su G. Safety assessment of 2D mxenes: in vitro and in vivo. Nanomaterials. 2022;12(5):828.","journal-title":"Nanomaterials"},{"key":"4084_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2022.113128","volume":"165","author":"L Yang","year":"2022","unstructured":"Yang L, Hu L, Tang H, Chen X, Liu X, Zhang Y, et al. The disruption of human trophoblast functions by autophagy activation through PI3K\/AKT\/mTOR pathway induced by exposure to titanium carbide (Ti3C2) MXene. Food Chem Toxicol. 2022;165:113128.","journal-title":"Food Chem Toxicol"},{"issue":"16","key":"4084_CR113","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.3390\/ma14164370","volume":"14","author":"B Rashid","year":"2021","unstructured":"Rashid B, Anwar A, Shahabuddin S, Mohan G, Saidur R, Aslfattahi N, et al. A comparative study of cytotoxicity of PPG and PEG surface-modified 2-D Ti3C2 MXene flakes on human cancer cells and their photothermal response. Materials. 2021;14(16):4370.","journal-title":"Materials"},{"issue":"18","key":"4084_CR114","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202101498","volume":"8","author":"X Zhao","year":"2021","unstructured":"Zhao X, Wang LY, Li JM, Peng LM, Tang CY, Zha XJ, et al. Redox-mediated artificial non\u2010enzymatic antioxidant MXene nanoplatforms for acute kidney injury alleviation. Adv Sci. 2021;8(18):2101498.","journal-title":"Adv Sci"},{"key":"4084_CR115","doi-asserted-by":"publisher","first-page":"101925","DOI":"10.1016\/j.nantod.2023.101925","volume":"51","author":"M Maruthupandy","year":"2023","unstructured":"Maruthupandy M, Rethinasabapathy M, Jeon S, Jeong J, Kim E, Lee S, et al. Role of reactive oxygen species in the toxicity of two-dimensional nanomaterials: a study on layered Ti3C2 MXenes. Nano Today. 2023;51:101925.","journal-title":"Nano Today"},{"issue":"1","key":"4084_CR116","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1038\/s41598-017-01714-3","volume":"7","author":"K Rasool","year":"2017","unstructured":"Rasool K, Mahmoud KA, Johnson DJ, Helal M, Berdiyorov GR, Gogotsi Y. Efficient antibacterial membrane based on two-dimensional Ti3C2Tx (MXene) nanosheets. Sci Rep. 2017;7(1):1598.","journal-title":"Sci Rep"},{"key":"4084_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104569","volume":"85","author":"S Sagadevan","year":"2023","unstructured":"Sagadevan S, Oh W-C. Comprehensive utilization and biomedical application of MXenes-a systematic review of cytotoxicity and biocompatibility. J Drug Deliv Sci Technol. 2023;85:104569.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"22","key":"4084_CR118","doi-asserted-by":"publisher","first-page":"13543","DOI":"10.1021\/acs.est.8b04444","volume":"52","author":"P Yuan","year":"2018","unstructured":"Yuan P, Zhou Q, Hu X. The phases of WS2 nanosheets influence uptake, oxidative stress, lipid peroxidation, membrane damage, and metabolism in algae. Environ Sci Technol. 2018;52(22):13543\u201352.","journal-title":"Environ Sci Technol"},{"issue":"2","key":"4084_CR119","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.matt.2019.05.020","volume":"1","author":"X Zhao","year":"2019","unstructured":"Zhao X, Vashisth A, Prehn E, Sun W, Shah SA, Habib T, et al. Antioxidants unlock shelf-stable Ti3C2Tx (MXene) nanosheet dispersions. Matter. 2019;1(2):513\u201326.","journal-title":"Matter"},{"issue":"47","key":"4084_CR120","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202000712","volume":"30","author":"D Xu","year":"2020","unstructured":"Xu D, Li Z, Li L, Wang J. Insights into the photothermal conversion of 2D MXene nanomaterials: synthesis, mechanism, and applications. Adv Funct Mater. 2020;30(47):2000712.","journal-title":"Adv Funct Mater"},{"issue":"9","key":"4084_CR121","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1039\/D1MA00189B","volume":"2","author":"S Iravani","year":"2021","unstructured":"Iravani S, Varma RS. MXenes and MXene-based materials for tissue engineering and regenerative medicine: recent advances. Mater Adv. 2021;2(9):2906\u201317.","journal-title":"Mater Adv"},{"issue":"10","key":"4084_CR122","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201800518","volume":"5","author":"H Lin","year":"2018","unstructured":"Lin H, Chen Y, Shi J. Insights into 2D MXenes for versatile biomedical applications: current advances and challenges ahead. Adv Sci. 2018;5(10):1800518.","journal-title":"Adv Sci"},{"issue":"18","key":"4084_CR123","doi-asserted-by":"publisher","first-page":"7633","DOI":"10.1021\/acs.chemmater.7b02847","volume":"29","author":"M Alhabeb","year":"2017","unstructured":"Alhabeb M, Maleski K, Anasori B, Lelyukh P, Clark L, Sin S, et al. Guidelines for synthesis and processing of two-dimensional titanium carbide (Ti3C2T x MXene). Chem Mater. 2017;29(18):7633\u201344.","journal-title":"Chem Mater"},{"key":"4084_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.compositesb.2019.107372","volume":"177","author":"X Lu","year":"2019","unstructured":"Lu X, Huang H, Zhang X, Lin P, Huang J, Sheng X, et al. Novel light-driven and electro-driven polyethylene glycol\/two-dimensional MXene form-stable phase change material with enhanced thermal conductivity and electrical conductivity for thermal energy storage. Composites Part B: Engineering. 2019;177:107372.","journal-title":"Composites Part B: Engineering"},{"key":"4084_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.apcatb.2022.122150","volume":"323","author":"K Gao","year":"2023","unstructured":"Gao K, Hou L-a, An X, Huang D, Yang Y. BiOBr\/MXene\/gC3N4 z-scheme heterostructure photocatalysts mediated by oxygen vacancies and MXene quantum dots for tetracycline degradation: process, mechanism and toxicity analysis. Appl Catal B Environ. 2023;323:122150.","journal-title":"Appl Catal B Environ"},{"issue":"1","key":"4084_CR126","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41545-022-00214-w","volume":"5","author":"X Chen","year":"2022","unstructured":"Chen X, Gudda FO, Hu X, Waigi MG, Gao Y. Degradation of bisphenol A in an oxidation system constructed from Mo2C MXene and peroxymonosulfate. NPJ Clean Water. 2022;5(1):66.","journal-title":"NPJ Clean Water"},{"issue":"2","key":"4084_CR127","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1021\/acsbiomaterials.3c01361","volume":"10","author":"M Safarkhani","year":"2024","unstructured":"Safarkhani M, Farasati Far B, Lima EC, Jafarzadeh S, Makvandi P, Varma RS, et al. Integration of MXene and microfluidics: a perspective. ACS Biomater Sci Eng. 2024;10(2):657\u201376.","journal-title":"ACS Biomater Sci Eng"},{"key":"4084_CR128","doi-asserted-by":"publisher","first-page":"133542","DOI":"10.1016\/j.chemosphere.2022.133542","volume":"293","author":"SS Siwal","year":"2022","unstructured":"Siwal SS, Sheoran K, Mishra K, Kaur H, Saini AK, Saini V, et al. Novel synthesis methods and applications of MXene-based nanomaterials (MBNs) for hazardous pollutants degradation: future perspectives. Chemosphere. 2022;293:133542.","journal-title":"Chemosphere"},{"key":"4084_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2024.03.032","author":"Z Zhu","year":"2024","unstructured":"Zhu Z, Chen T, Wu Y, Wu X, Lang Z, Huang F, et al. Microfluidic strategies for engineering oxygen-releasing biomaterials. Acta Biomater. 2024. https:\/\/doi.org\/10.1016\/j.actbio.2024.03.032.","journal-title":"Acta Biomater"},{"key":"4084_CR130","doi-asserted-by":"publisher","first-page":"100281","DOI":"10.1016\/j.flatc.2021.100281","volume":"29","author":"O Folorunso","year":"2021","unstructured":"Folorunso O, Kumar N, Hamam Y, Sadiku R, Ray SS. Recent progress on 2D metal carbide\/nitride (MXene) nanocomposites for lithium-based batteries. FlatChem. 2021;29:100281.","journal-title":"FlatChem"},{"key":"4084_CR131","doi-asserted-by":"publisher","first-page":"109331","DOI":"10.1016\/j.microc.2023.109331","volume":"194","author":"JR de Jesus","year":"2023","unstructured":"de Jesus JR, de Sousa Pereira MV, Ribeiro IS, de Araujo Andrade T, de Carvalho JP, de Tarso Garcia P, et al. Multifunctional and eco-friendly nanohybrid materials as a green strategy for analytical and bioanalytical applications: Advances, potential and challenges. Microchem J. 2023;194:109331.","journal-title":"Microchem J"},{"key":"4084_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2024.151230","author":"B G\u00fcrb\u00fcz","year":"2024","unstructured":"G\u00fcrb\u00fcz B, Ciftci F. Bio-electric-electronics and tissue engineering applications of MXenes wearable materials: a review. Chem Eng J. 2024. https:\/\/doi.org\/10.1016\/j.cej.2024.151230.","journal-title":"Chem Eng J"},{"key":"4084_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114178","volume":"184","author":"H Huang","year":"2022","unstructured":"Huang H, Dong C, Feng W, Wang Y, Huang B, Chen Y. Biomedical engineering of two-dimensional MXenes. Adv Drug Deliv Rev. 2022;184:114178.","journal-title":"Adv Drug Deliv Rev"},{"key":"4084_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.snb.2023.133342","volume":"380","author":"H Duan","year":"2023","unstructured":"Duan H, Wang Y, Tang S-Y, Xiao T-H, Goda K, Li M. A CRISPR-Cas12a powered electrochemical sensor based on gold nanoparticles and MXene composite for enhanced nucleic acid detection. Sens Actuators B Chem. 2023;380:133342.","journal-title":"Sens Actuators B Chem"},{"key":"4084_CR135","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202410535","author":"J Jia","year":"2024","unstructured":"Jia J, Zhang X, Li Y, Wang T, An Y, Yan X, et al. Remotely sequential activation of biofunctional MXenes for spatiotemporally controlled photothermal cancer therapy integrated with multimodal imaging. Small. 2024. https:\/\/doi.org\/10.1002\/smll.202410535.","journal-title":"Small"},{"issue":"6","key":"4084_CR136","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.1021\/acsabm.1c00332","volume":"4","author":"N Rabiee","year":"2021","unstructured":"Rabiee N, Bagherzadeh M, Jouyandeh M, Zarrintaj P, Saeb MR, Mozafari M, et al. Natural polymers decorated MOF-MXene nanocarriers for co-delivery of doxorubicin\/pCRISPR. ACS Appl Bio Mater. 2021;4(6):5106\u201321.","journal-title":"ACS Appl Bio Mater"},{"key":"4084_CR137","doi-asserted-by":"crossref","unstructured":"Khondakar KR, Tripathi D, Mazumdar H, Ahuja K, Kaushik A. Tailored MXene and graphene as efficient telemedicine platforms for personalized health wellness. Mater Adv. 2024; 5(5): 1771\u20131789.","DOI":"10.1039\/D4MA00234B"},{"key":"4084_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtcomm.2024.109929","author":"AM Amani","year":"2024","unstructured":"Amani AM, Tayebi L, Vafa E, Jahanbin A, Abbasi M, Vaez A, et al. Innovation applications of MXenes in biomedicine. Mater Today Commun. 2024. https:\/\/doi.org\/10.1016\/j.mtcomm.2024.109929.","journal-title":"Mater Today Commun"},{"issue":"10","key":"4084_CR139","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.3390\/mi13101773","volume":"13","author":"F Mohajer","year":"2022","unstructured":"Mohajer F, Ziarani GM, Badiei A, Iravani S, Varma RS. Advanced MXene-based micro-and nanosystems for targeted drug delivery in cancer therapy. Micromachines. 2022;13(10):1773.","journal-title":"Micromachines"},{"issue":"22","key":"4084_CR140","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202201734","volume":"9","author":"Z Li","year":"2022","unstructured":"Li Z, Lai X, Fu S, Ren L, Cai H, Zhang H, et al. Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency. Adv Sci. 2022;9(22):2201734.","journal-title":"Adv Sci"},{"key":"4084_CR141","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S457782","author":"J Peng","year":"2024","unstructured":"Peng J, Li S, Ti H. Sensitize tumor immunotherapy: immunogenic cell death inducing nanosystems. Int J Nanomedicine. 2024. https:\/\/doi.org\/10.2147\/IJN.S457782.","journal-title":"Int J Nanomedicine"},{"key":"4084_CR142","doi-asserted-by":"publisher","first-page":"121034","DOI":"10.1016\/j.biomaterials.2021.121034","volume":"276","author":"CW Beh","year":"2021","unstructured":"Beh CW, Yew DS, Chai RJ, Chin SY, Seow Y, Hoon SS. A fluid-supported 3D hydrogel bioprinting method. Biomaterials. 2021;276:121034.","journal-title":"Biomaterials"},{"issue":"11","key":"4084_CR143","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1007\/s13346-024-01572-3","volume":"14","author":"VK Deb","year":"2024","unstructured":"Deb VK, Jain U. Ti3C2 (MXene), an advanced carrier system: role in photothermal, photoacoustic, enhanced drugs delivery and biological activity in cancer therapy. Drug Deliv Transl Res. 2024;14(11):3009\u201331.","journal-title":"Drug Deliv Transl Res"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04084-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-04084-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04084-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:03:48Z","timestamp":1768395828000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-025-04084-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":143,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4084"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-04084-3","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to the content of the manuscript and publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}